About Us | Contact

Alex S Befeler Investigator

Gastroenterology Ssm Health Saint Louis University Hospital NPI1881602753
Update NPI

Open Payments

Note

The following payment details are based on a national transparency program known as the Sunshine Act that collects and publishes information about financial relationships between the health care industry (i.e. drug and device manufactures) and providers. These relationships may involve payment to providers for things such as research, speaking engagment, travel, gifts etc. Not all of these payment involve monetary compensations and may include batering of drugs or devices.

Total Payment Worth

$28,057.11
from 54 payments in the last 6 years

Total Cash or Cash Equivalent

$24,087.71
from 18 payments in the last 6 years

Total In-kind Items & Services

$3,969.40
from 36 payments in the last 6 years

Nature of Payments

Last 6 Years
Chart will render here...

Yearly Breakdown

Chart will render here...

Payment Details

Date Payment Type Form of Payment Item/Service Payment Amount
10/20/2021 General (Non-Research) In-kind items and services Food and Beverage $16.70 Details
Payment from Gilead Sciences, Inc.
Payment Record ID 848162033
12/02/2021 General (Non-Research) In-kind items and services Food and Beverage $17.80 Details
Payment from Dynavax Technologies Corporation
Payment Record ID 800993431
03/10/2020 General (Non-Research) In-kind items and services Food and Beverage $1.27 Details
Payment from Gilead Sciences, Inc.
Payment Record ID 747953949
04/01/2020 General (Non-Research) In-kind items and services Travel and Lodging $563.49 Details
Payment from Gilead Sciences, Inc.
Payment Record ID 743823599
04/01/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $2230.00 Details
Payment from Gilead Sciences, Inc.
Payment Record ID 743815377
12/02/2020 General (Non-Research) In-kind items and services Education $35.93 Details
Payment from AbbVie Inc.
Payment Record ID 721693755
11/10/2019 General (Non-Research) In-kind items and services Food and Beverage $72.85 Details
Payment from Mallinckrodt Enterprises LLC
Payment Record ID 703448465
12/24/2019 Research Cash or cash equivalent Drug $200.00 Details
Payment from Bausch Health US, LLC
Paymment Research Study A RANDOMIZED DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING, MULTICENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF RIFAXIMIN SOLUBLE DISPERSION SSD TABLETS PLUS LACTULOSE AND RIFAXIMIN EXTENDED INTESTINAL RELEASE EIR TABLETS PLUS LACTULOSE FOR THE TREATMENT OF OVERT HEPATIC ENCEPHALOPATHY OHE.
Clinical Trials Gov ID NCT03515044
Payment Record ID 684328661
12/24/2019 Research Cash or cash equivalent Drug $200.00 Details
Payment from Bausch Health US, LLC
Paymment Research Study A RANDOMIZED DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING, MULTICENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF RIFAXIMIN SOLUBLE DISPERSION SSD TABLETS PLUS LACTULOSE AND RIFAXIMIN EXTENDED INTESTINAL RELEASE EIR TABLETS PLUS LACTULOSE FOR THE TREATMENT OF OVERT HEPATIC ENCEPHALOPATHY OHE.
Clinical Trials Gov ID NCT03515044
Payment Record ID 684328655
12/24/2019 Research Cash or cash equivalent Drug $200.00 Details
Payment from Bausch Health US, LLC
Paymment Research Study A RANDOMIZED DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING, MULTICENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF RIFAXIMIN SOLUBLE DISPERSION SSD TABLETS PLUS LACTULOSE AND RIFAXIMIN EXTENDED INTESTINAL RELEASE EIR TABLETS PLUS LACTULOSE FOR THE TREATMENT OF OVERT HEPATIC ENCEPHALOPATHY OHE.
Clinical Trials Gov ID NCT03515044
Payment Record ID 684328653
12/24/2019 Research Cash or cash equivalent Drug $200.00 Details
Payment from Bausch Health US, LLC
Paymment Research Study A RANDOMIZED DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING, MULTICENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF RIFAXIMIN SOLUBLE DISPERSION SSD TABLETS PLUS LACTULOSE AND RIFAXIMIN EXTENDED INTESTINAL RELEASE EIR TABLETS PLUS LACTULOSE FOR THE TREATMENT OF OVERT HEPATIC ENCEPHALOPATHY OHE.
Clinical Trials Gov ID NCT03515044
Payment Record ID 684328647
10/10/2019 Research Cash or cash equivalent Drug $789.58 Details
Payment from Bausch Health US, LLC
Paymment Research Study A RANDOMIZED DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING, MULTICENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF RIFAXIMIN SOLUBLE DISPERSION SSD TABLETS PLUS LACTULOSE AND RIFAXIMIN EXTENDED INTESTINAL RELEASE EIR TABLETS PLUS LACTULOSE FOR THE TREATMENT OF OVERT HEPATIC ENCEPHALOPATHY OHE.
Clinical Trials Gov ID NCT03515044
Payment Record ID 684328643
10/10/2019 Research Cash or cash equivalent Drug $205.85 Details
Payment from Bausch Health US, LLC
Paymment Research Study A RANDOMIZED DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING, MULTICENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF RIFAXIMIN SOLUBLE DISPERSION SSD TABLETS PLUS LACTULOSE AND RIFAXIMIN EXTENDED INTESTINAL RELEASE EIR TABLETS PLUS LACTULOSE FOR THE TREATMENT OF OVERT HEPATIC ENCEPHALOPATHY OHE.
Clinical Trials Gov ID NCT03515044
Payment Record ID 684328639
10/10/2019 Research In-kind items and services Drug $518.00 Details
Payment from Bausch Health US, LLC
Paymment Research Study A RANDOMIZED DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING, MULTICENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF RIFAXIMIN SOLUBLE DISPERSION SSD TABLETS PLUS LACTULOSE AND RIFAXIMIN EXTENDED INTESTINAL RELEASE EIR TABLETS PLUS LACTULOSE FOR THE TREATMENT OF OVERT HEPATIC ENCEPHALOPATHY OHE.
Clinical Trials Gov ID NCT03515044
Payment Record ID 684328632
05/14/2019 Research Cash or cash equivalent Drug $1484.00 Details
Payment from Bausch Health US, LLC
Paymment Research Study A RANDOMIZED DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING, MULTICENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF RIFAXIMIN SOLUBLE DISPERSION SSD TABLETS PLUS LACTULOSE AND RIFAXIMIN EXTENDED INTESTINAL RELEASE EIR TABLETS PLUS LACTULOSE FOR THE TREATMENT OF OVERT HEPATIC ENCEPHALOPATHY OHE.
Clinical Trials Gov ID NCT03515044
Payment Record ID 684328629
05/14/2019 Research Cash or cash equivalent Drug $1530.55 Details
Payment from Bausch Health US, LLC
Paymment Research Study A RANDOMIZED DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING, MULTICENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF RIFAXIMIN SOLUBLE DISPERSION SSD TABLETS PLUS LACTULOSE AND RIFAXIMIN EXTENDED INTESTINAL RELEASE EIR TABLETS PLUS LACTULOSE FOR THE TREATMENT OF OVERT HEPATIC ENCEPHALOPATHY OHE.
Clinical Trials Gov ID NCT03515044
Payment Record ID 684328622
05/14/2019 Research Cash or cash equivalent Drug $1895.17 Details
Payment from Bausch Health US, LLC
Paymment Research Study A RANDOMIZED DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING, MULTICENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF RIFAXIMIN SOLUBLE DISPERSION SSD TABLETS PLUS LACTULOSE AND RIFAXIMIN EXTENDED INTESTINAL RELEASE EIR TABLETS PLUS LACTULOSE FOR THE TREATMENT OF OVERT HEPATIC ENCEPHALOPATHY OHE.
Clinical Trials Gov ID NCT03515044
Payment Record ID 684328617
05/14/2019 Research Cash or cash equivalent Drug $1895.17 Details
Payment from Bausch Health US, LLC
Paymment Research Study A RANDOMIZED DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING, MULTICENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF RIFAXIMIN SOLUBLE DISPERSION SSD TABLETS PLUS LACTULOSE AND RIFAXIMIN EXTENDED INTESTINAL RELEASE EIR TABLETS PLUS LACTULOSE FOR THE TREATMENT OF OVERT HEPATIC ENCEPHALOPATHY OHE.
Clinical Trials Gov ID NCT03515044
Payment Record ID 684328613
05/14/2019 Research Cash or cash equivalent Drug $1895.17 Details
Payment from Bausch Health US, LLC
Paymment Research Study A RANDOMIZED DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING, MULTICENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF RIFAXIMIN SOLUBLE DISPERSION SSD TABLETS PLUS LACTULOSE AND RIFAXIMIN EXTENDED INTESTINAL RELEASE EIR TABLETS PLUS LACTULOSE FOR THE TREATMENT OF OVERT HEPATIC ENCEPHALOPATHY OHE.
Clinical Trials Gov ID NCT03515044
Payment Record ID 684328609
05/14/2019 Research Cash or cash equivalent Drug $1531.46 Details
Payment from Bausch Health US, LLC
Paymment Research Study A RANDOMIZED DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING, MULTICENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF RIFAXIMIN SOLUBLE DISPERSION SSD TABLETS PLUS LACTULOSE AND RIFAXIMIN EXTENDED INTESTINAL RELEASE EIR TABLETS PLUS LACTULOSE FOR THE TREATMENT OF OVERT HEPATIC ENCEPHALOPATHY OHE.
Clinical Trials Gov ID NCT03515044
Payment Record ID 684328603
05/14/2019 Research Cash or cash equivalent Drug $1895.17 Details
Payment from Bausch Health US, LLC
Paymment Research Study A RANDOMIZED DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING, MULTICENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF RIFAXIMIN SOLUBLE DISPERSION SSD TABLETS PLUS LACTULOSE AND RIFAXIMIN EXTENDED INTESTINAL RELEASE EIR TABLETS PLUS LACTULOSE FOR THE TREATMENT OF OVERT HEPATIC ENCEPHALOPATHY OHE.
Clinical Trials Gov ID NCT03515044
Payment Record ID 684328599
05/14/2019 Research Cash or cash equivalent Drug $1895.17 Details
Payment from Bausch Health US, LLC
Paymment Research Study A RANDOMIZED DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING, MULTICENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF RIFAXIMIN SOLUBLE DISPERSION SSD TABLETS PLUS LACTULOSE AND RIFAXIMIN EXTENDED INTESTINAL RELEASE EIR TABLETS PLUS LACTULOSE FOR THE TREATMENT OF OVERT HEPATIC ENCEPHALOPATHY OHE.
Clinical Trials Gov ID NCT03515044
Payment Record ID 684328592
11/09/2019 General (Non-Research) In-kind items and services Food and Beverage $125.00 Details
Payment from Gilead Sciences, Inc.
Payment Record ID 681479145
08/01/2019 General (Non-Research) In-kind items and services Food and Beverage $3.57 Details
Payment from Gilead Sciences, Inc.
Payment Record ID 681479143
03/15/2019 General (Non-Research) In-kind items and services Food and Beverage $3.30 Details
Payment from Gilead Sciences, Inc.
Payment Record ID 681479141
02/25/2019 General (Non-Research) In-kind items and services Food and Beverage $3.42 Details
Payment from Gilead Sciences, Inc.
Payment Record ID 681479139
08/28/2018 General (Non-Research) In-kind items and services Food and Beverage $40.59 Details
Payment from Allergan Inc.
Payment Record ID 594779133
06/08/2018 General (Non-Research) In-kind items and services Food and Beverage $17.00 Details
Payment from Janssen Biotech, Inc.
Payment Record ID 548913373
10/24/2018 General (Non-Research) In-kind items and services Food and Beverage $99.00 Details
Payment from ERBE USA Inc
Payment Record ID 535604281
10/22/2017 Research In-kind items and services $42.00 Details
Payment from Mallinckrodt LLC
Paymment Research Study A MULTI-CENTER, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY TO CONFIRM EFFICACY AND SAFETY OF TERLIPRESSIN IN SUBJECTS WITH HEPATORENAL SYNDROME TYPE 1
Payment Record ID 508272843
12/08/2017 General (Non-Research) In-kind items and services Food and Beverage $17.81 Details
Payment from Gilead Sciences Inc
Payment Record ID 480270565
12/01/2017 General (Non-Research) In-kind items and services Food and Beverage $2.18 Details
Payment from Gilead Sciences Inc
Payment Record ID 480270563
02/03/2017 General (Non-Research) In-kind items and services Food and Beverage $26.13 Details
Payment from Gilead Sciences Inc
Payment Record ID 480270561
02/03/2017 General (Non-Research) In-kind items and services Travel and Lodging $20.52 Details
Payment from Gilead Sciences Inc
Payment Record ID 480232375
01/07/2017 General (Non-Research) In-kind items and services Travel and Lodging $488.58 Details
Payment from Gilead Sciences Inc
Payment Record ID 480232373
01/07/2017 General (Non-Research) In-kind items and services Travel and Lodging $331.99 Details
Payment from Gilead Sciences Inc
Payment Record ID 480232371
01/07/2017 General (Non-Research) In-kind items and services Travel and Lodging $220.00 Details
Payment from Gilead Sciences Inc
Payment Record ID 480232369
01/07/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $3000.00 Details
Payment from Gilead Sciences Inc
Payment Record ID 480213533
03/02/2017 General (Non-Research) In-kind items and services Food and Beverage $86.81 Details
Payment from BOSTON SCIENTIFIC CORPORATION
Payment Record ID 455575075
12/04/2017 General (Non-Research) In-kind items and services Food and Beverage $19.18 Details
Payment from Janssen Biotech, Inc.
Payment Record ID 449551777
06/09/2017 General (Non-Research) In-kind items and services Food and Beverage $19.23 Details
Payment from Janssen Biotech, Inc.
Payment Record ID 449551767
11/15/2017 General (Non-Research) In-kind items and services Food and Beverage $58.62 Details
Payment from Valeant Pharmaceuticals North America LLC
Payment Record ID 444209275
09/28/2016 Research In-kind items and services $55.00 Details
Payment from INO Therapeutics LLC
Paymment Research Study A MULTI-CENTER, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY TO CONFIRM EFFICACY AND SAFETY OF TERLIPRESSIN IN SUBJECTS WITH HEPATORENAL SYNDROME TYPE 1
Payment Record ID 414913013
09/23/2016 Research Cash or cash equivalent $40.42 Details
Payment from INO Therapeutics LLC
Paymment Research Study A MULTI-CENTER, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY TO CONFIRM EFFICACY AND SAFETY OF TERLIPRESSIN IN SUBJECTS WITH HEPATORENAL SYNDROME TYPE 1
Payment Record ID 414913009
05/14/2016 General (Non-Research) In-kind items and services Food and Beverage $47.28 Details
Payment from Gilead Sciences Inc
Payment Record ID 391184970
05/14/2016 General (Non-Research) In-kind items and services Food and Beverage $114.65 Details
Payment from Gilead Sciences Inc
Payment Record ID 391184953
05/14/2016 General (Non-Research) In-kind items and services Food and Beverage $7.29 Details
Payment from Gilead Sciences Inc
Payment Record ID 391184938
05/14/2016 General (Non-Research) In-kind items and services Food and Beverage $49.55 Details
Payment from Gilead Sciences Inc
Payment Record ID 391184926
05/14/2016 General (Non-Research) Cash or cash equivalent Consulting Fee $3000.00 Details
Payment from Gilead Sciences Inc
Payment Record ID 390220680
05/14/2016 General (Non-Research) In-kind items and services Travel and Lodging $240.37 Details
Payment from Gilead Sciences Inc
Payment Record ID 389754474
05/14/2016 General (Non-Research) In-kind items and services Travel and Lodging $360.96 Details
Payment from Gilead Sciences Inc
Payment Record ID 389754454
05/14/2016 General (Non-Research) In-kind items and services Travel and Lodging $205.40 Details
Payment from Gilead Sciences Inc
Payment Record ID 389754436
12/02/2016 General (Non-Research) In-kind items and services Food and Beverage $19.95 Details
Payment from Janssen Biotech, Inc.
Payment Record ID 365229592
06/03/2016 General (Non-Research) In-kind items and services Food and Beverage $17.98 Details
Payment from Janssen Biotech, Inc.
Payment Record ID 365197928
;